Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of Lucentis in the Management of New Onset Neovascular Glaucoma

NCT00727038 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT00727038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00727038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of Lucentis in the Management of New Onset Neovascular Glaucoma
Lead sponsor
University of Illinois at Chicago
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 4, 2008
Completion date
May 15, 2009
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, neovascular glaucoma, new onset glaucoma, new onset neovascular glaucoma